Prospective Evaluation of Shoulder Arthroplasty Outcomes
Research type
Research Study
Full title
An Open Label, Multi-Center, Retrospective and Prospective Evaluation
IRAS ID
331097
Contact name
Rumbi Muchemwa
Contact email
Sponsor organisation
Exactech Inc
Duration of Study in the UK
11 years, 11 months, 2 days
Research summary
This study is a post-market clinical follow up of the Equinoxe shoulder arthroplasty system which aims to treat the shoulder by offering pain relief and restoration of joint functionality. The Equinoxe implants are licensed for use and currently CER markets. The purpose of this study is to collect and evaluate long-term clinical and radiographic safety and performance outcomes following shoulder arthroplasty in order to better understand the safety, effectiveness, performance, and implant survival of shoulder arthroplasty over time (up to 10 years).
REC name
East Midlands - Leicester Central Research Ethics Committee
REC reference
24/EM/0032
Date of REC Opinion
30 Sep 2024
REC opinion
Further Information Favourable Opinion